Neogenomics Inc (NASDAQ:NEO)

4.21
Data as of Jul 11
 -0.09 / -2.09%
Today’s Change
2.05
Today|||52-Week Range
4.69
+16.30%
Year-to-Date
SECTOR
Health Services
INDUSTRY
Medical/Nursing Services
MARKET CAP
$209.2M

Company Description

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories to provide genetic and molecular testing services. The company offers various testing services, including Cytogenetics, Fluorescence In-Situ Hybridization, Flow Cytometry, Immunohistochemistry and Molecular testing. It offers testing services to hospitals, pathologists, oncologists, other clinicians and researchers. The company was founded by Michael T. Dent on October 29, 1998 and is headquartered in Fort Myers, FL.

Contact Information

NeoGenomics, Inc.
12701 Commonwealth Drive
Fort Myers Florida 33913
P:(239) 768-0600
Investor Relations:
(239) 325-2001

Employees

Shareholders

Mutual fund holders7.50%
Other institutional41.83%
Individual stakeholders25.18%

Top Executives

Douglas M. VanOortExecutive Chairman & Chief Executive Officer
Edwin F. WeidigChief Accounting Officer & Finance Director
George A. CardozaChief Financial Officer
Robert P. GaspariniChief Scientific Officer
Maher AlbitarChief Medical Officer

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.